QUOTE AND NEWS
Benzinga  May 13  Comment 
Pluristem Therapeutics (NSDAQ: PSTI) announced today its PLacental eXpanded (PLX) cells tested in preclinical animal models of preeclampsia effectively improved several parameters of the disease. The study was conducted in collaboration with Brett...
Benzinga  May 7  Comment 
Pluristem Therapeutics Inc. (NASDAQ: PSTI) announced today that it has identified its first clinical indication in the hematology field for its Placental eXpanded (PLX) RAD cells for the enhancement of the engraftment of Hematopoietic Stem Cells...
StreetInsider.com  Apr 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pluristem+Therapeutics+%28PSTI%29+Says+United+Therapeutics+Receives+OK+for+Human+Study+with+PLX-PAD+/8247453.html for the full story.
Benzinga  Mar 19  Comment 
Jefferies initiated coverage on Pluristem Therapeutics (NASDAQ: PSTI) with a Hold rating and a $3.50 price target. Jefferies analyst Eun K. Yang commented, "Positives for PSTI include (1) real unmet need/large market potential in peripheral...
StreetInsider.com  Jan 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pluristem+%28PSTI%29+Receives+Approval+to+Commence+PLX-PAD+Phase+II+in+Germany/8008688.html for the full story.
StreetInsider.com  Nov 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pluristem+%28PSTI%29+Needs+to+Provide+More+Info+to+FDA+Over+PLX+Cells+Oprhan+Drug+App/7896898.html for the full story.
Benzinga  Nov 9  Comment 
Pluristem Therapeutics (NASDAQ: PSTI) offered comments on an article published in Bloomberg on November 7, 2012. Pluristem has submitted a direct request to Bloomberg to publish a correction because the article it published is factually...
StreetInsider.com  Oct 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pluristem+%28PSTI%29+Initiates+IQ+Process+at+cGMP+Facility/7809785.html for the full story.
StreetInsider.com  Oct 17  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pluristem+%28PSTI%29+Reports+Reduction+in+Fibrotic+Processes+w+PLX+Cells/7797836.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki